Literature DB >> 10453005

Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.

N S Williams1, J Klem, I J Puzanov, P V Sivakumar, M Bennett, V Kumar.   

Abstract

To delineate factors involved in NK cell development, we established an in vitro system in which lineage marker (Lin)-, c-kit+, Sca2+ bone marrow cells differentiate into lytic NK1.1+ but Ly49- cells upon culture in IL-7, stem cell factor (SCF), and flt3 ligand (flt3L), followed by IL-15 alone. A comparison of the ability of IL-7, SCF, and flt3L to generate IL-15-responsive precursors suggested that NK progenitors express the receptor for flt3L. In support of this, when Lin-, c-kit+, flt3+ or Lin-, c-kit+, flt3- progenitors were utilized, 3-fold more NK cells arose from the flt3+ than from the flt3- progenitors. Furthermore, NK cells that arose from flt3- progenitors showed an immature NK1.1dim, CD2-, c-kit+ phenotype as compared with the more mature NK1.1bright, CD2+/-, c-kit- phenotype displayed by NK cells derived from flt3+ progenitors. Both progenitors, however, gave rise to NK cells that were Ly49 negative. To test the hypothesis that additional marrow-derived signals are necessary for Ly49 expression on developing NK cells, flt3+ progenitors were grown in IL-7, SCF, and flt3L followed by culture with IL-15 and a marrow-derived stromal cell line. Expression of Ly49 molecules, including those of which the MHC class I ligands were expressed on the stromal or progenitor cells, as well as others of which the known ligands were absent, was induced within 6-13 days. Thus, we have established an in vitro system in which Ly49 expression on developing NK cells can be analyzed and possibly experimentally manipulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453005

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow.

Authors:  John W Fathman; Deepta Bhattacharya; Matthew A Inlay; Jun Seita; Holger Karsunky; Irving L Weissman
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

Review 2.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Development of thymic NK cells from double negative 1 thymocyte precursors.

Authors:  Claudia L Vargas; Jennifer Poursine-Laurent; Liping Yang; Wayne M Yokoyama
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

Review 4.  ID'ing innate and innate-like lymphoid cells.

Authors:  Mihalis Verykokakis; Erin C Zook; Barbara L Kee
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

5.  A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro.

Authors:  Patrick Ming-Kuen Tang; Philip Chiu-Tsun Tang; Jeff Yat-Fai Chung; Jessica Shuk Chun Hung; Qing-Ming Wang; Guang-Yu Lian; Jingyi Sheng; Xiao-Ru Huang; Ka-Fai To; Hui-Yao Lan
Journal:  J Vis Exp       Date:  2018-01-09       Impact factor: 1.355

6.  Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Authors:  C M Hennies; R A Reboulet; Z Garcia; S Nierkens; M C Wolkers; E M Janssen
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 7.  NK cell development, homeostasis and function: parallels with CD8⁺ T cells.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2011-08-26       Impact factor: 53.106

8.  Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture.

Authors:  Sunwoong S Choi; Vaninder S Chhabra; Quoc H Nguyen; Bonnie J Ank; E Richard Stiehm; Robert L Roberts
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

9.  Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation.

Authors:  Eliseo F Castillo; Spencer W Stonier; Loredana Frasca; Kimberly S Schluns
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

Review 10.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.